Annual Conference
22 September 2026 – Basel, Switzerland
Program Committee
Thomas Wejs Møller (Chair)
Novo Nordisk
Karoline Mathys
Swissmedic
Sabina Hoekstra-van den Bosch
TÜV SÜD
Marianne Silkjær Nielsen
Compcure
Malte Kladiwa
Novartis
Erhard Huesler
Ypsomed
